Nestle’s $6,000 Peanut Allergy Pill Has Been a Dud

An anonymous reader quotes a report from Bloomberg: When Nestle SA’s peanut allergy medicine first hit the market in 2020, Robert Wood, the director of pediatric allergy at Johns Hopkins Hospital in Baltimore, started preparing to offer it to the child…

Read More >>